Monday, April 29, 2024

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

Treating cognitive decline after cholestatic liver disease

Treating cognitive decline after cholestatic liver disease

Patients with cholestatic liver disease may develop neurological symptoms including fatigue and cognitive decline, for which there is currently no cure.  Cholestatic liver diseases such...
Re-examining the safety of fluoroquinolones

Re-examining the safety of fluoroquinolones

A review into the use of fluoroquinolones has found discrepancies in the safety data issued by regulatory bodies. Fluoroquinolones are commonly prescribed family of antibiotics....
New Alzheimer’s drug Lecanemab shows promising results in trial 

New Alzheimer’s drug Lecanemab shows promising results in trial 

A new clinical trial for lecanemab reveals positive results for the future of Alzheimer’s disease treatment.  Study results presented at the 15th Clinical Trials on Alzheimer’s...
Blood thinning medication does not help COVID-19 recovery

Blood thinning medication does not help COVID-19 recovery

Blood thinning medication does not help patients recovering from COVID-19, despite being offered to patients, according to research from the University of Cambridge.  Over 1,000...
High-precision medicine can improve treatment for ovarian cancer

High-precision medicine can improve treatment for ovarian cancer

An international team of researchers have found that high-precision medicines can be used in oncology, allowing for better treatment for ovarian cancer. Mutations of BRCA1...
New life-extending treatment recommended for rare gastroesophageal cancer

New life-extending treatment recommended for rare gastroesophageal cancer

Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer. Gastroesophageal cancer, also known as gastroesophageal...
NICE approve mobocertinib to treat aggressive lung cancer

NICE approve mobocertinib to treat aggressive lung cancer

Around 100 people will benefit from mobocertinib, a new treatment for rare and aggressive lung cancer after NICE published its final guidance on recommending...
Lisdexamfetamine is the safest medication for people with drug addiction

Lisdexamfetamine is the safest medication for people with drug addiction

Lisdexamfetamine, a medication for ADHD, has the lowest risk of hospitalisation and death in people with amphetamine addiction, according to research from Karolinska Institutet...
The bacteria behind leprosy disease could regenerate livers

The bacteria behind leprosy disease could regenerate livers

In a groundbreaking discovery, researchers have found that parasites behind leprosy disease can reprogramme cells to increase the size of a liver. The latest findings...
A potential new type 1 diabetes medication has been discovered

A potential new type 1 diabetes medication has been discovered

A new type 1 diabetes medication could prevent the disease by inhibiting a gene associated with the onset of the disease, according to the...
A new treatment for lung cancer has been identified

A new treatment for lung cancer has been identified

Researchers have identified a potential new treatment for lung cancer, which could also aid early detection of the disease. Scientists investigating the mechanics of the...
Sustainable health system innovation in the medical cold chain

Sustainable health system innovation in the medical cold chain

With a portfolio of medical refrigeration devices boasting green credentials, B Medical Systems is providing robust cold chain solutions for sustainable health systems. Sustainability is...
Anti-cholesterol and diabetes drugs may reduce the risk of eye disease

Anti-cholesterol and diabetes drugs may reduce the risk of eye disease

Regularly taking anti-cholesterol and diabetes drugs may lessen the risk of degenerative eye disease associated with ageing, according to new research. Findings from a pooled...
Bivalirudin is the safest treatment for percutaneous coronary intervention

Bivalirudin is the safest treatment for percutaneous coronary intervention

Researchers have found that bivalirudin is a safer and more effective anticoagulant than heparin for treating percutaneous coronary intervention patients. The researchers found that heart...
Reducing the risk of stomach bleeding after long-term aspirin use 

Reducing the risk of stomach bleeding after long-term aspirin use 

A new study by the University of Nottingham found that the risk of stomach bleeding caused by long-term aspirin use can be reduced with...
A single dose of psilocybin reduces depression symptoms 

A single dose of psilocybin reduces depression symptoms 

A large clinical trial has found that a single 25mg dose of COMP360 psilocybin had a significant impact on depression symptoms in participants with...
Researchers begin development of new endometrial cancer treatment

Researchers begin development of new endometrial cancer treatment 

An international research team has identified a new therapeutic strategy to combat endometrial cancer and has begun developing a new treatment.   The new therapy is...
A large-scale study of common blood thinners identifies the safest option

A large-scale study of common blood thinners identifies the safest option

A large-scale comparison of blood thinners by researchers from University College London has identified the drugs with the lowest risk of gastrointestinal bleeding.   The researchers...
Dentists prescribed excessive antibiotics for toothache in pandemic  

Dentists prescribed excessive antibiotics for toothache in pandemic  

A new report from the University of Manchester highlights that dentists were forced to prescribe unnecessary antibiotics for toothache during the pandemic.  In the UK,...
Experimental liver cancer treatment provides new care options

Experimental liver cancer treatment provides new care options

A new drug, discovered by the University of Barcelona, that can inhibit cell division and growth in enzymes could revolutionise liver cancer treatment. The new...

Featured Special Reports

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest